New Venture Capital Firm Vensana has Orthopedic Roots
Vensana Capital announced a $225 million fund to build a portfolio of 10 to 12 companies. The firm's founders have...
The move positions RESOMER as the reportedly largest, most differentiated portfolio of functional biomaterials for implantable devices....
This latest iteration of the M2 machine delivers increased part quality, consistency and productivity with enhanced usability and maintainability....
DePuy Synthes and Stryker combined hold more than 50% of the market share in the $7 billion+ trauma segment....
The company recently doubled its manufacturing space, increasing capacity to support customers in the global orthopedic market....
This release includes support for prepackaged, application-specific nTop Toolkits, letting engineers quickly learn and use powerful capabilities right out of...